Literature DB >> 28857073

Pancreatic cancer: TCGA data reveal a highly heterogeneous disease.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28857073     DOI： 10.1038/nrclinonc.2017.146

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Authors: 
Journal:  Cancer Cell       Date:  2017-08-14       Impact factor: 31.743
  1 in total
  10 in total

1.  A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.

Authors:  Nguyen Phuoc Long; Sang Jun Yoon; Nguyen Hoang Anh; Tran Diem Nghi; Dong Kyu Lim; Yu Jin Hong; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolomics       Date:  2018-08-10       Impact factor: 4.290

2.  A Pan-Cancer Analysis Revealing the Dual Roles of Lysine (K)-Specific Demethylase 6B in Tumorigenesis and Immunity.

Authors:  Jia-Tong Ding; Xiao-Ting Yu; Jin-Hao He; De-Zhi Chen; Fei Guo
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

Review 3.  Precision medicine in pancreatic cancer: treating every patient as an exception.

Authors:  Brian Herbst; Lei Zheng
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10

4.  High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Authors:  Ming Cui; Lei You; Bang Zheng; Xinmei Huang; Qiaofei Liu; Jing Huang; Boju Pan; Xiaoyan Qiu; Quan Liao; Yupei Zhao
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

5.  Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer.

Authors:  Yue Fan; Tianyu Li; Lili Xu; Tiantao Kuang
Journal:  Comput Math Methods Med       Date:  2020-09-30       Impact factor: 2.238

6.  Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma via bioinformatic analysis and in vitro experiments.

Authors:  Xiaohua Lei; Guodong Chen; Jiangtao Li; Wu Wen; Jian Gong; Jie Fu
Journal:  PeerJ       Date:  2021-09-06       Impact factor: 2.984

7.  Cullin-5 (CUL5) as a potential prognostic marker in a pan-cancer analysis of human tumors.

Authors:  Zian Li; Nan Hu; Lirui Dai; Xuelei Hou; Weihua Hu; Wulong Liang; Xinjun Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 8.  Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.

Authors:  Divya Thomas; Prakash Radhakrishnan
Journal:  Mol Cancer       Date:  2019-01-21       Impact factor: 27.401

9.  DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer.

Authors:  Shuhang Qin; Yuandong Liao; Qiqiao Du; Wei Wang; Jiaming Huang; Pan Liu; Chunliang Shang; Tianyu Liu; Meng Xia; Shuzhong Yao
Journal:  Cancer Cell Int       Date:  2020-06-03       Impact factor: 5.722

Review 10.  The clinical application of 18F-FDG PET/CT in pancreatic cancer: a narrative review.

Authors:  Yongzhu Pu; Chun Wang; Sheng Zhao; Ran Xie; Lei Zhao; Kun Li; Conghui Yang; Rui Zhang; Yadong Tian; Lixian Tan; Jindan Li; Shujuan Li; Long Chen; Hua Sun
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.